Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder

ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis

Polanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt261 · Cited by 1,822

Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Wolraich, M. L., Hagan, J. F., Allan, C., Chan, E., Davison, D., Earls, M., Evans, S. W., Flinn, S. K., Froehlich, T., Frost, J., et al. (2019) · Pediatrics · doi:10.1542/peds.2019-2528 · Cited by 1,562

Attention-deficit/hyperactivity disorder

Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479

Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis

Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30269-4 · Cited by 1,402

Meta-analysis of Functional Magnetic Resonance Imaging Studies of Inhibition and Attention in Attention-deficit/Hyperactivity Disorder: Exploring Task-Specific, Stimulant Medication, and Age Effects

Hart, H., Radua, J., Nakao, T., Mataix-Cols, D., & Rubia, K. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.277 · Cited by 764

Brain imaging of the cortex in ADHD: a coordinated analysis of large-scale clinical and population-based samples

Hoogman, M., Muetzel, R., Guimaraes, J. P., Shumskaya, E., Mennes, M., Zwiers, M. P., Jahanshad, N., Sudre, G., Wolfers, T., Earl, E. A., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18091033 · Cited by 467

Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

Leucht, S., Hierl, S., Kissling, W., Dold, M., & Davis, J. M. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.096594 · Cited by 451

Practitioner Review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents

Cortese, S., Holtmann, M., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Graham, J., Taylor, E., Sergeant, J., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12036 · Cited by 336

Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis

Rubia, K., Alegria, A. A., Cubillo, A. I., Smith, A. B., Brammer, M. J., & Radua, J. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.016 · Cited by 315

Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.

Raman, S. R., Man, K. K. C., Bahmanyar, S., Bérard, A., Bilder, S., Boukhris, T., Bushnell, G., Crystal, S., Furu, K., KaoYang, Y.-H., et al. (2018) · Lancet psychiatry · doi:10.1016/s2215-0366(18)30293-1 · Cited by 285

Association Between Pharmacological Treatment of Attention-Deficit/Hyperactivity Disorder and Long-term Unemployment Among Working-Age Individuals in Sweden

Li, L., Chang, Z., Sun, J., Jangmo, A., Zhang, L., Andersson, L. M., Werner‐Kiechle, T., Ahnemark, E., D'Onofrio, B. M., & Larsson, H. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.6815 · Cited by 14

Potential effectiveness of digital therapeutics specialized in executive functions as adjunctive treatment for clinical symptoms of attention-deficit/hyperactivity disorder: a feasibility study

Sun, T. H., Yeom, J. W., Choi, K., Kim, J. L., Lee, H., Kim, H. J., & Cho, C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1169030 · Cited by 14

Efficacy and Safety of Methylphenidate and Atomoxetine in Medication-Naive Children with Attention-Deficit Hyperactivity Disorder in a Real-World Setting

Zhang, Y., Yin, L., You, C., Liu, C., Dong, P., Xu, X., & Zhang, K. (2023) · Drugs in R&D · doi:10.1007/s40268-023-00445-3 · Cited by 13

Management of sleep disorders in autism spectrum disorder with co-occurring attention-deficit hyperactivity disorder: update for clinicians

Petti, T. A., Gupta, M., Fradkin, Y., & Gupta, N. (2023) · BJPsych Open · doi:10.1192/bjo.2023.589 · Cited by 14

How Frequent Is Switching From an Initial Stimulant Family to the Alternative One in the Clinical Setting?

Biederman, J., DiSalvo, M., Green, A., Woodworth, K. Y., Law, C., Gabrieli, J. D. E., & Faraone, S. V. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001374 · Cited by 14

New insights into precocious puberty and ADHD: a nationwide cohort study

Pai, L.-F., Wang, D.-S., Hsu, W.-F., Huang, S.-W., Chung, C., Chen, S., Chien, W., & Chu, D. (2022) · Pediatric Research · doi:10.1038/s41390-022-02028-5 · Cited by 13

The Effect of SMS Reminders on Adherence in a Self-Guided Internet-Delivered Intervention for Adults With ADHD

Nordby, E. S., Gjestad, R., Kenter, R. M. F., Guribye, F., Mukhiya, S. K., Lundervold, A. J., & Nordgreen, T. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.821031 · Cited by 16

Healthcare pathways and practitioners’ knowledge about ADHD in children

Willig, T.-N., Dajon, M., Assathiany, R., Brun, L., Fourneret, P., Massé, M., Monge, A., Piollet, A., Thiollier, M. C., Cortese, S., et al. (2023) · L Encéphale · doi:10.1016/j.encep.2023.07.005 · Cited by 13

SKILLS – A psychoeducational group programme for children with ADHD

Lantz, S., Fornwall, C., Lööf, M., & Isaksson, J. (2021) · Scandinavian Journal of Psychology · doi:10.1111/sjop.12727 · Cited by 13

Rates of switching stimulants in consecutively referred medication naïve adults with ADHD

Biederman, J., DiSalvo, M., Green, A., Woodworth, K. Y., Gilfix, T., Law, C., Gabrieli, J. D. E., & Faraone, S. V. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13370 · Cited by 13

Cognitive Impairment in Survivors of Pediatric Extracranial Solid Tumors and Lymphomas

Foster, R. H., Zheng, D. J., Netson, K. L., & Kadan‐Lottick, N. S. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.02358 · Cited by 12

Long-Term Cardiovascular Effects of Medications for Attention-Deficit/Hyperactivity Disorder—Balancing Benefits and Risks of Treatment

Cortese, S., & Fava, C. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.4126 · Cited by 11

Outcomes of a 12-week ecologically valid observational study of first treatment with methylphenidate in a representative clinical sample of drug naïve children with ADHD

Kaalund-Brok, K., Houmann, T., Hebsgaard, M. B., Lauritsen, M.-B. G., Lundstrøm, L. H., Grønning, H., Darling, L., Reinert-Petersen, S., Petersen, M. A., Jepsen, J. R. M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253727 · Cited by 13

Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended‐release in children and adolescents with attention‐deficit/hyperactivity disorder

Nasser, A., Kosheleff, A. R., Hull, J. T., Liranso, T., Qin, P.-B., Busse, G., Fava, M., Maletić, V., Rubin, J., & López, F. (2021) · International journal of clinical practice · doi:10.1111/ijcp.14330 · Cited by 11

Normative growth modeling of brain morphology reveals neuroanatomical heterogeneity and biological subtypes in children with ADHDPreprint

Bu, X., Zhao, Y., Zheng, X., Fu, Z., Zhang, K., Sun, X., Cui, Z., Xia, M., Ma, L., Liu, N., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.16.582202 · Cited by 10

A 5-week Digital Intervention to Reduce Attention Problems in Children With ADHD: A Double-Blind Randomized Controlled Trial

Kirk, H., Richmond, S., Gaunson, T., Bennett, M., Herschtal, A., Bellgrove, M., & Cornish, K. (2024) · Journal of Attention Disorders · doi:10.1177/10870547241256269 · Cited by 7

Genome Guided Personalized Drug Therapy in Attention Deficit Hyperactivity Disorder

Haavik, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.925442 · Cited by 11

Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD

Cataldo, M., Donnelly, G. A. E., Cutler, A. J., Childress, A. C., Mikl, J., Bhaskar, S., & Waxmonsky, J. G. (2022) · Journal of Attention Disorders · doi:10.1177/10870547221106238 · Cited by 10

Attention-Deficit/Hyperactivity Disorder and the Gut Microbiota–Gut–Brain Axis: Closing Research Gaps through Female Inclusion in Study Design

Schleupner, H. V., & Carmichael, M. J. (2022) · Women · doi:10.3390/women2030023 · Cited by 11

A Counting Stroop Functional Magnetic Resonance Imaging Study on the Effects of ORADUR-Methylphenidate in Drug-Naive Children with Attention-Deficit/Hyperactivity Disorder

Shang, C., Chou, T., Hsieh, C.-Y., & Gau, S. S. (2022) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2022.0024 · Cited by 10

Associations Between Attention-Deficit/Hyperactivity Disorder (ADHD), ADHD Medication, and Shorter Height: A Quasi-Experimental and Family-Based Study

Ahlberg, R., Garcia‐Argibay, M., Rietz, E. D., Butwicka, A., Cortese, S., D'Onofrio, B. M., Ludvigsson, J. F., & Larsson, H. (2023) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2023.03.015 · Cited by 12

Risk of Respiratory Infectious Diseases and the Role of Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder: A Population-Based Cohort Study

Li, D., Chen, Y., Hsiao, R. C.-J., Chen, H., & Yen, C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18115824 · Cited by 11

Methylphenidate Differentially Affects Intrinsic Functional Connectivity of the Salience Network in Adult ADHD Treatment Responders and Non-Responders

Ulrich, M., Heckel, K., Kölle, M. A., & Grön, G. (2022) · Biology · doi:10.3390/biology11091320 · Cited by 10

Effect of ADHD medication on risk of injuries: a preference-based instrumental variable analysis

Widding‐Havneraas, T., Elwert, F., Markussen, S., Zachrisson, H. D., Lyhmann, I., Chaulagain, A., Bjelland, I., Halmøy, A., Rypdal, K., & Mykletun, A. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-023-02294-6 · Cited by 9

Association between stimulant and non-stimulant ADHD medications and completed suicide in adolescents and adults: A population-based nested case-control study

Vasiliadis, H., Rochette, L., Massamba, V. K., LESAGE, A. D., Rahme, E., Gignac, M., Diallo, F. B., Fansi, A. K., Cortese, S., & Lunghi, C. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116309 · Cited by 9

The Role of Epigenetics in the Pathogenesis and Potential Treatment of Attention Deficit Hyperactivity Disorder

Peedicayil, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210920091036 · Cited by 9

Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up

Weiss, M. D., Surman, C. B. H., Khullar, A., Owens, J. A., He, E., Cataldo, M., & Donnelly, G. A. E. (2021) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2021.0087 · Cited by 9

Memory training with the method of loci for children and adolescents with ADHD—A feasibility study

Ruchkin, V. V., Wallonius, M., Odekvist, E., Kim, S., & Isaksson, J. (2022) · Applied Neuropsychology Child · doi:10.1080/21622965.2022.2141120 · Cited by 10

Pioglitazone enhances brain mitochondrial biogenesis and phase II detoxification capacity in neonatal rats with 6-OHDA-induced unilateral striatal lesions

Vázquez-González, D., & Corona, J. C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1186520 · Cited by 9

Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genotyping and therapeutic drug monitoring to dance together

Guo, H., Wu, D., Fu, D., Li, Y., Wang, J., Zhang, Y., Wang, W., Huang, J., Fang, W., Xu, J., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02859-2 · Cited by 10

Disruption of Pharmacotherapy During the Transition from Adolescence to Early Adulthood in Patients with Attention-Deficit/Hyperactivity Disorder: A Claims Database Analysis Across the USA

Farahbakhshian, S., Ayyagari, R., Barczak, D. S., Gill, S. K., Tang, W., Kulalert, T., Jenkins, M. D., & Spalding, W. M. (2021) · CNS Drugs · doi:10.1007/s40263-021-00808-x · Cited by 9

The adverse association between stimulant use for attention deficit hyperactivity disorder (ADHD) and semen parameters

Pham, M. N., Hudnall, M. T., Fantus, R. J., Lai, J. D., Ambulkar, S. S., Wren, J. M., Bennett, N., Auffenberg, G. B., Chu, D. I., Brannigan, R. E., et al. (2021) · Andrologia · doi:10.1111/and.14315 · Cited by 9

Pharmacological Interventions for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents with Tourette Disorder: A Systematic Review and Network Meta-Analysis

Farhat, L. C., Behling, E., Landeros‐Weisenberger, A., de Barros, P. M. F., Polanczyk, G. V., Cortese, S., & Bloch, M. H. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2024.0049 · Cited by 10

Effects of methylphenidate on blood pressure, QT-interval, and cardiac output in ADHD diagnosed children: A three months’ follow-up study

Omidi, N., Ghorashi, S. M., Tajrishi, F. Z., Effatpanah, M., Khatami, F., & Khorgami, M. (2021) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2021.100805 · Cited by 8

Acute Tolerability of Methylphenidate in Treatment-Naïve Children with ADHD: An Analysis of Naturalistically Collected Data from Clinical Practice

Masi, G., Pfanner, C., Liboni, F., Lenzi, F., Villafranca, A., D’Acunto, G., Fantozzi, P., Falcone, F., Simonelli, V., Muratori, P., et al. (2022) · Pediatric Drugs · doi:10.1007/s40272-022-00492-4 · Cited by 8

Response of peer relations and social activities to treatment with viloxazine extended‐release capsules (Qelbree ® ): A post hoc analysis of four randomized clinical trials of children and adolescents with attention‐deficit/hyperactivity disorder

Faraone, S. V., Goméni, R., Hull, J. T., Busse, G. D., Lujan, B., Rubin, J. S., & Nasser, A. F. (2023) · Brain and Behavior · doi:10.1002/brb3.2910 · Cited by 7

A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder

Abbas, K., Barnhardt, E. W., Nash, P. L., Streng, M., & Coury, D. L. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2321921 · Cited by 7

Definition of Response in Randomized Controlled Trials of Medications for Attention-Deficit/Hyperactivity Disorder Across the Lifespan: A Systematic Review

Roy, S., Colacicco, G., Frigeri, G., Tarantino, F., Matera, E., Petruzzelli, M. G., & Cortese, S. (2025) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2025.0029 · Cited by 7

Effectiveness and User Experience of Immersive Virtual Reality in Cognitive Rehabilitation for Attention-Deficit/Hyperactivity Disorder: Systematic Review

Single, N., Graham, W. M., Kelson, J. N., & Sulikowski, D. (2025) · JMIR Mental Health · doi:10.2196/71963 · Cited by 9

Effect of Atomoxetine on Behavioral Difficulties and Growth Development of Primary School Children with Attention-Deficit/Hyperactivity Disorder: A Prospective Study

Mei, H., Xie, R., Li, T., Chen, Z., Liu, Y., & Sun, C. (2022) · Children · doi:10.3390/children9020212 · Cited by 7

The Burden of Attention-Deficit Hyperactivity Disorder (ADHD) in the Middle East and North Africa Region, 1990 to 2019

Safiri, S., Mousavi, S. E., Nejadghaderi, S. A., Noori, M., Sullman, M. J. M., Amiri, S., & Kolahi, A. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231187161 · Cited by 8

Dichotomous effect of methylphenidate on microglia and astrocytes: Insights from in vitro and animal studies

Novo, J. P., Muga, M., Lourenço, T., Sanches, E. S., Leitão, R. A., & Silva, A. P. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.10.008 · Cited by 7

Clinical Study of Limosilactobacillus reuteri for the Treatment of Children with Chronic Tic Disorders/Tourette Syndrome: A Mid-Term Efficacy Evaluation

Liang, Y., Wan, L., Wang, G., Yan, H., Zhang, J., Liu, X., Zhang, Z. Y., Zhu, G., & Yang, G. (2024) · Neurology and Therapy · doi:10.1007/s40120-024-00693-8 · Cited by 7

A Randomized, Placebo-Controlled Laboratory Classroom Study of the Efficacy and Safety of Dasotraline in Children With ADHD

Wigal, S. B., Tsai, J., Bates, J. A., Sarma, K., Tortorich, D., Zhu, H., & GOLDMAN, R. S. (2022) · Journal of Attention Disorders · doi:10.1177/10870547211073477 · Cited by 7

Effects of methylphenidate on subjective sleep parameters in adults with ADHD: a prospective, non-randomized, non-blinded 6-week trial

Low, A.-M., Vangkilde, S., le Sommer, J., Fagerlund, B., Glenthoj, B. Y., Jepsen, J. R. M., & Habekost, T. (2022) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2022.2080253 · Cited by 8

Guidelines in the United States for the Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Why They Are Needed

Childress, A. C., Sibley, M., Solanto, M. V., Wiznitzer, M., & Newcorn, J. H. (2023) · Psychiatric Annals · doi:10.3928/00485713-20230911-04 · Cited by 8

Attention-Deficit Hyperactivity Disorder Stimulant Therapy and Prescription Drug Misuse During Transition to Young Adulthood

McCabe, S. E., Schulenberg, J. E., Wilens, T. E., Schepis, T. S., Werner, K. S., McCabe, V. V., & Veliz, P. T. (2024) · Psychiatric Services · doi:10.1176/appi.ps.20230418 · Cited by 7

The Impact of Methylphenidate on Sexual Functions: A Systematic Review of Benefits and Risks

Bieś, R., Szewczyk, Z., Warchała, A., Martyniak, E., & Krzystanek, M. (2025) · Pharmaceuticals · doi:10.3390/ph18050718 · Cited by 6

Treatment Adherence in ADHD: A Systematic Review of Influencing Factors and Strategies for Improvement

Karimi, M., Ghasemzadeh, S., & Fami, F. S. (2025) · Journal of Attention Disorders · doi:10.1177/10870547251387006 · Cited by 7

Extended-Release Viloxazine for the Treatment of Attention-Deficit Hyperactivity Disorder in School-Age Children and Adolescents

Raible, H., & D’Souza, M. S. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231163252 · Cited by 6

Predicting the Response of Children and Adolescents With ADHD to Methylphenidate: A Systematic Review

Pagnier, M. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231177234 · Cited by 6

Long-term medication for ADHD (LMA) trial: 2-year prospective observational study in children and adolescents. Core symptoms, daily functioning, and comorbidity outcomes

Johnson, M., Johnels, J. Å., Östlund, S., Jakobsson, K., Högstedt, J., Larsson, P. J., Gillberg, C., & Billstedt, E. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01744-1 · Cited by 7

Single–dose methylphenidate induces shift in functional connectivity associated with positive longer term clinical response in adult attention–deficit/hyperactivity disorder

Pretzsch, C. M., Parlatini, V., & Murphy, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-87204-3 · Cited by 10

A clinician’s guide for navigating the world of attention deficit hyperactivity disorder medications

Mattingly, G., & Young, J. (2021) · CNS Spectrums · doi:10.1017/s1092852921000146 · Cited by 5

Pharmacological and non-pharmacological interventions for adults with ADHD: protocol for a systematic review and network meta-analysis

Cortese, S., Giovane, C. D., Chamberlain, S. R., Philipsen, A., Young, S., Bilbow, A., & Cipriani, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058102 · Cited by 6

Improvement of attention deficit/hyperactivity disorder (ADHD) in three adult men during testosterone treatment: a case series

Rogne, A. G., & Hassel, B. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-022-03651-w · Cited by 6

Association between methylphenidate and risk of myocardial infarction: A multinational self‐controlled case series study

Jeong, H. E., Lee, H., Lai, E. C., Liao, T., Man, K. K. C., Wong, I. C. K., Coghill, D., Chi, M., Hsieh, C., & Shin, J. (2021) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5322 · Cited by 6

Resting-State fMRI to Identify the Brain Correlates of Treatment Response to Medications in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Lessons From the CUNMET Study

Pereira-Sánchez, V., Franco, A. R., de Castro‐Manglano, P., Fernández‐Seara, M. A., Vallejo-Valdivielso, M., Díez‐Suárez, A., Fernández-Martínez, M., de Eulate, M. R. G., Milham, M. P., Soutullo, C. A., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.759696 · Cited by 6

Psychotic symptoms during pharmacological treatment of ADHD: clinical considerations and research needs

Cortese, S., Garcia‐Argibay, M., Oliver, D., Chang, Z., Farhat, L. C., Bloch, M. H., de Pablo, G. S., Larsson, H., Solmi, M., Correll, C. U., et al. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00248-2 · Cited by 7

Efficacy and safety of transcranial alternating current stimulation in adults with attention deficit hyperactivity disorder: a double-blind randomized sham-controlled trial

Fu, Z., Tian, J., Kang, S., Qin, Z., Cao, Q., Wang, Y., Deng, J., & Yang, L. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03407-0 · Cited by 7

Pharmacological interventions for ADHD: a systematic review and dose–effect network meta-analysis

Nourredine, M., Jurek, L., Hamza, T., Cipriani, A., Subtil, F., Parlatini, V., Farhat, L. C., Veronesi, G. F., Efthimiou, O., Salanti, G., et al. (2026) · The Lancet Psychiatry · doi:10.1016/s2215-0366(26)00091-x · Cited by 6

Withdrawing methylphenidate in relation to serum levels of ferritin and zinc in children and adolescents with attention-deficit/hyperactivity disorder

Rosenau, P. T., van den Hoofdakker, B. J., Matthijssen, A. M., van de Loo-Neus, G. H. H., Buitelaar, J. K., Hoekstra, P. J., & Dietrich, A. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.06.014 · Cited by 5

Efficacy and tolerability of psychostimulants for symptoms of attention-deficit hyperactivity disorder in preschool children: A systematic review and meta-analysis

Chiu, H., Sun, C., Cheng, Y., Wang, M. Y., Tzang, R., Lin, F.-L., Cheng, Y., & Chung, W. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.11 · Cited by 5

Attitudes of South Australian psychiatrists towards attention deficit hyperactivity disorder in adults

Cao, C., Deakin, C., & Gill, S. (2023) · Australasian Psychiatry · doi:10.1177/10398562231211132 · Cited by 5

First promising non-stimulant (guanfacine) transdermal patch for long-acting treatment of ADHD by solid dispersion technique

Hou, Z., Zhao, X., & Ding, J. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106117 · Cited by 5

Effects of mind-body exercise on individuals with ADHD: a systematic review and meta-analysis

Peng, J., Wang, W., Wang, Y., Hu, F., & Jia, M. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1490708 · Cited by 12

Brain structural changes and the development of interference control in children with ADHD: The predictive value of physical activity and body mass index

Ludyga, S., & Ishihara, T. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103141 · Cited by 10

Attention deficit hyperactivity disorder, physical abuse and methylphenidate treatment in children

Man, K. K. C., Gao, L., Lau, W. C. Y., Fan, M., Coghill, D., Chan, E. W., Chui, C. S. L., Li, X., Chan, A. Y. L., Lum, T. Y. S., et al. (2023) · Nature Mental Health · doi:10.1038/s44220-022-00008-6 · Cited by 5

Efficacy and Safety of SPN-812 (Extended-Release Viloxazine) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis

Tan, X., Xu, Y., Wang, S., Li, J., Hu, C., Chen, Z., Cheng, Q., & Wang, Z. (2023) · Brain Sciences · doi:10.3390/brainsci13121627 · Cited by 5

Diabetes Glycemic Control in Adults With Type 2 Diabetes Mellitus and ADHD

Leshno, D., Lev-Shalem, L., Gavze, R. P., & Leshno, M. (2024) · Journal of Attention Disorders · doi:10.1177/10870547241288720 · Cited by 4

Pharmaceutical Supply Chains: A Structural Determinant of Health for Children With ADHD

Keeton, V. F. (2024) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2024.11.001 · Cited by 4

Genome-wide DNA methylation analysis of hippocampal tissue in a murine model of attention deficit-hyperactivity disorder

Vidal, R., Lopez, I., Ugarte, G., Contreras, D., Piña, R., Godoy, F., Rozas, C., Rubio, D., Mantellero, C. A., Constandil, L., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323756 · Cited by 4

Efficacy and Compliance of a Working Memory Multitasking Task Mobile Intervention for Children With Attention-Deficit/Hyperactivity Disorder: Single-Arm, Pre-Post Pilot Study

Jung, M., Woo, J., Kim, S. J., Lim, Y. B., Kim, Y., Kang, D., Min, J., & Kim, B.-N. (2025) · JMIR Human Factors · doi:10.2196/70479 · Cited by 4

External trigeminal nerve stimulation in youth with ADHD: a randomized, sham-controlled, phase 2b trial

Conti, A. A., Bozhilova, N. S., Eraydin, I. E., Stringer, D., Johansson, L. C., Marhenke, R., Bilbow, A., Masri, S. E., Hyde, J., Giaroli, G., et al. (2026) · Nature Medicine · doi:10.1038/s41591-025-04075-x · Cited by 5

Medication Management of Neuropsychiatric Symptoms in Neurological Conditions: A Dimensional Transdiagnostic Approach

Anderson, J., & Schrift, M. J. (2022) · Seminars in Neurology · doi:10.1055/s-0041-1742144 · Cited by 4

Cardiovascular Considerations for Stimulant Class Medications

Hammerness, P. G., Berger, A. C., Angelini, M. C., & Wilens, T. E. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.02.002 · Cited by 4

Common practical questions – and answers – at the British Association for Psychopharmacology child and adolescent psychopharmacology course

Cortese, S., Besag, F., Clark, B., Hollis, C. P., Kilgariff, J., Moreno, C., Nicholls, D., Wilkinson, P. O., Woodbury‐Smith, M., & Sharma, A. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221140005 · Cited by 4

One year follow-up of participants in a randomised controlled trial of a CBT-based group therapy programme for adolescents diagnosed with ADHD

Andersen, A. C., Sund, A. M., Thomsen, P. H., Lydersen, S., Young, S., & Nøvik, T. S. (2024) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2024.2301774 · Cited by 4

Methylphenidate triggers retinal oxidative stress and mitochondrial dysfunction under physiological conditions but has beneficial effects in inflammatory settings

Sanches, E. S., Leitão, R. A., Baptista, F. I., Mota, S. I., Caldeira, M. V., Oliveira, P. J., Ambrósio, A. F., Fernandes, R., & Silva, A. P. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110623 · Cited by 4

Atomoxetine-Associated Eyebrow Alopecia in a Girl With Attention-Deficit/Hyperactivity Disorder

Zhang, Y., Xu, X., & Zhang, K. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001454 · Cited by 4

Association of treatment procedures and resilience to symptom load three-years later in a clinical sample of adolescent psychiatric patients

Gårdvik, K. S., Rygg, M., Torgersen, T., Wallander, J. L., Lydersen, S., & Indredavik, M. S. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03417-6 · Cited by 5

Viloxazine for attention-deficit hyperactivity disorder: a new formulation for a new indication

Balasundaram, M. K., & Singh, A. D. (2022) · Drugs & Therapy Perspectives · doi:10.1007/s40267-022-00892-z · Cited by 4

Clinicians' Adherence to Guidelines When Initiating Methylphenidate Treatment

Matthijssen, A. M., Dietrich, A., Deters, R. K., Meinardi, Y., del Canho, R., van de Loo-Neus, G. H. H., Buitelaar, J. K., van den Hoofdakker, B. J., & Hoekstra, P. J. (2022) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2022.0060 · Cited by 4

Perspectives on heterogeneity-informed cognitive training for attention-deficit/hyperactivity disorder

Zhang, D. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1100008 · Cited by 4

Discontinuation of methylphenidate after long-term exposure in nonhuman primates

Zhang, X., Berridge, M. S., Apana, S. M., Slikker, W., Paule, M. G., & Talpos, J. C. (2023) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2023.107173 · Cited by 4

Evaluating serdexmethylphenidate and dexmethylphenidate capsules as a once-daily treatment option for ADHD

Barnhardt, E., Narayanan, A. R., & Coury, D. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2218544 · Cited by 2

In silico clinical trial evaluating lisdexamfetamine’s and methylphenidate’s mechanism of action computational models in an attention-deficit/hyperactivity disorder virtual patients’ population

Gutiérrez-Casares, J. R., Quintero, J., Segú-Vergés, C., Monterde, P. R., Pozo-Rubio, T., Coma, M., & Montoto, C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.939650 · Cited by 5

Dopamine, Norepinephrine and Serotonin Participate Differently in Methylphenidate Action in Concomitant Behavioral and Ventral Tegmental Area, Locus Coeruleus and Dorsal Raphe Neuronal Study in Young Rats

Reyes-Vasquez, C., Jones, Z., Tang, B., & Dafny, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316628 · Cited by 4

Bifidobacterium breve during infancy attenuates mobility in low birthweight rats

Itoh, A., Tanaka, N., Fukunaga, S., Nakano‐Doi, A., Matsuyama, T., Nakagomi, T., & Tsuji, M. (2022) · Pediatrics International · doi:10.1111/ped.15209 · Cited by 4

Beyond Diagnosis: Formulation–Storytelling and Maps

Hoyos, C., & Cortese, S. (2022) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2022.06.008 · Cited by 4

Treating Attention-Deficit/Hyperactivity Disorder Matters

LEVIN, F. R., Hernández, M., & Mariani, J. J. (2024) · JAMA · doi:10.1001/jama.2024.1755 · Cited by 4

Atomoxetine Decreases Mitochondrial Biogenesis, Fission and Fusion In Human Neuron-like Cells But Does Not Alter Antioxidant Defences

Carreón-Trujillo, S., Vázquez-González, D., & Corona, J. C. (2022) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-022-01116-x · Cited by 3

Exploring psychological capital, self-esteem, and well-being in students with attention deficit hyperactivity disorder: mediation and treatment differences

Hazan‐Liran, B., & Walter, O. (2025) · European Journal of Special Needs Education · doi:10.1080/08856257.2025.2549574 · Cited by 3

Real-world effectiveness of a widely available digital health program in adults reporting a lifetime diagnosis of ADHD

Osman, A. M., Madore, K. P., Jaffe, P. I., Offidani, E., Childress, A. C., Newcorn, J. H., & Schafer, R. J. (2025) · npj Mental Health Research · doi:10.1038/s44184-025-00157-3 · Cited by 3

Effects of physical activity on cognition, behavior, and hyperactivity symptoms in elementary school children with adhd

Carmen, C., Agustín, A.-A., Javier, C.-S., & Alberto, R.-A. (2025) · Acta Psychologica · doi:10.1016/j.actpsy.2025.105913 · Cited by 4

Systematic Review: Assessment of Blinding Integrity in 161 Randomized Controlled Trials of Medications for Attention-Deficit/Hyperactivity Disorder

Veronesi, G. F., Huneke, N. T. M., Shah, M., & Cortese, S. (2024) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2024.07.926 · Cited by 3

A review on ADHD disorder, diagnosis and therapeutic approach in children and adolescents

Kumar, G., Sharma, B., Tiwari, R. K., Kumar, R., & Singh, M. K. (2024) · Brain-Apparatus Communication A Journal of Bacomics · doi:10.1080/27706710.2024.2400070 · Cited by 4

Do I Have ADHD? Diagnosis of ADHD in Adulthood and Its Mimics in the Neurology Clinic

Mierau, S. B. (2024) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200433 · Cited by 7

Effectiveness and safety of dexamphetamine sulfate (Attentin ® ) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional study

Uebel, H., Dangel, O., Fischer, R., Ruhmann, M., & Huß, M. (2021) · Scandinavian Journal of Child and Adolescent Psychiatry and Psychology · doi:10.21307/sjcapp-2021-009 · Cited by 4

Conduct problems, hyperactivity, and screen time among community youth: can mindfulness help? an exploratory study

Kim, S., Munten, S., Kolla, N. J., & Thege, B. K. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1248963 · Cited by 3

The Pharmacotherapeutics of Methylphenidate and Atomoxetine for the Treatment of Childhood and Adolescent Attention Deficit-Hyperactivity Disorder

Sibbald, C., Sterling, W. J., Bennett, M., McNally, O., & Rogers, K. (2012) · Journal of Healthcare · doi:10.36959/569/451

Tratamiento actual del trastorno por déficit de atención e hiperactividad (TDAH) Actual treatment of attention defi cit hyperactivity disorder (ADHD)

Palomino, D., Guerrero, C. P., & Martín-Calero, J. (2013) · Cited by 1

The efficacy of methylphenidate and atomoxetine forvoiding dysfunction associated with attention deficit hyperactivity disorder

Tajima, D. (2017) · Japanese Society of Child Neurology

Pharmacological management of attention-deficit hyperactivity disorder

Reeves, G. M., & Schweitzer, J. B. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.6.1313 · Cited by 24

Current Pharmacological Treatments for ADHD

Groom, M. J., & Cortese, S. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_330 · Cited by 74